Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPartner with us to develop biosimilar products more quickly and cost effectively – from clinical and operational planning to pipeline prioritization and feasibility analyses to full-service study execution.
Biosimilars transform care for patients with cancer, immune diseases, and other illnesses at significant savings compared to reference biological medicines. Regulators are accelerating approval paths for biosimilars yet require clinical trials in patients. Comparative studies demand a CRO with a proven track record in biosimilars to help sponsors understand the biologics landscape, drive patient enrollment, navigate regulations, and conduct flexible trials.
IQVIA’s Biosimilars Center of Excellence (COE) partners with sponsors to optimize the velocity, integrity, and value of every biosimilars study using market intelligence, proven best practices, strategy and protocol development, trial operations, regulatory support, as well as medical and clinical expertise across therapeutic areas. Engage early with this COE on an operational blueprint, comparator sourcing, and feasibility analysis.
Gain instant access to regulatory insights and timely guidance from national authorities around the world. This intelligence helps customers avoid resource-intensive collection of regulatory information, reduce margin for error, and prepare for FDA and EMA reviews. Learn more.
The IQVIA Institute examines the current state of biosimilars market opportunities in different geographic regions and therapeutic areas. These reports assess factors impacting biosimilar uptake, including reimbursement and provider type. The IQVIA Institute also consolidates publicly available information on preclinical development and trial registries in a global biosimilars database. Learn more about the U.S. market outlook.
The biosimilars Center of Excellence has a 360-degree understanding of key trends, new compounds in the pipeline, the reference business outlook for biologics, and the patent expiry timetable. Our team applies insights about the state of the art in biosimilars clinical development to help sponsors assess their R&D assets and optimize biosimilar investments.
IQVIA network of partner sites benefit biosimilar sponsors in numerous ways. These sites are pre-qualified and have collaborated with strong operational efficiencies during previous trials, which enhances patient recruitment, speeds activation times, and improves data delivery. Learn more.
IQVIA’s specialists help sponsors find the most direct route from breakthrough science to new therapies. Collaborate with IQVIA clinical development, laboratory, medical, R&D, biostatistics, and other domain experts. Draw upon Oncology, GI, and CNS specialists for complex biosimilar development profiles. Learn more.
Leverage IQVIA’s management of clinical workloads and advanced analytics capabilities to assess recruitment, drop-out rates, visits, and other crucial patient data; compare site performance on sample and endpoint collection; and evaluate early safety data. Operational insights from these analyses can streamline study scale and timelines. Learn more.
Tap into the power of the IQVIA Connected Intelligence™ to help achieve study outcomes and bring biosimilar drugs to market faster.
Competition, Savings, and Sustainability
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
Understand the science in treating diabetes with broadening populations, expanding treatment options, and new digital support tools.
Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
